Levin S L
Clinic of Nervous Diseases and Neurosurgery, Medical Pediatric College, Leningrad, U.S.S.R.
J Neural Transm. 1988;73(3):239-47. doi: 10.1007/BF01250139.
Intense salivatory reactions to atropine appear only at the second and are completely at the third stage of the postdenervational syndrome. Muscarinic receptors, emerging at these stages of denervation and causing paradoxical reactions to cholinolytics, differ from those which emerge at the first stage of denervation and from those blocked with atropine. A classical antagonist, atropine is able to discriminate between heterogenous subpopulations of these receptors, emerging at various stages of denervation. The denervated parotid gland presents, an evolving system in terms of muscarinic receptors. Atropine discriminates between the highest levels in the development of those structures and the lowest ones, since for the former it plays the role of an antagonist, and for the latter the role of an agonist.
对阿托品的强烈唾液分泌反应仅出现在去神经综合征的第二阶段,在第三阶段则完全出现。在这些去神经阶段出现并导致对胆碱能阻滞剂产生反常反应的毒蕈碱受体,与在去神经第一阶段出现的受体以及被阿托品阻断的受体不同。作为一种经典拮抗剂,阿托品能够区分在去神经不同阶段出现的这些受体的异质亚群。就毒蕈碱受体而言,去神经的腮腺呈现出一个不断演变的系统。阿托品区分这些结构发育中的最高水平和最低水平,因为对于前者它起拮抗剂的作用,而对于后者则起激动剂的作用。